C. Moran et al., 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study, AM J OBST G, 183(6), 2000, pp. 1468-1474
OBJECTIVE: Our aim was to determine whether the clinical features of 21-hyd
roxylase-deficient nonclassic adrenal hyperplasia are correlated with eithe
r age at symptom onset or age at presentation, or both, and with the degree
of adrenocortical abnormality. STUDY
DESIGN: In a multicenter cohort design 220 women with nonclassic adrenal hy
perplasia, with a basal or adrenocorticotropic hormone-stimulated 17-hydrox
yprogesterone level >30.3 nmol/L, were studied, either prospectively (n = 3
9) or retrospectively (n = 181). Patients were stratified by age of present
ation into 5 groups: (1) <10 years (n = 25), (2) 10 to 19 years (n = 64), (
3) 20 to 29 years (n = 83), (4) 30 to 39 years (n = 30), and (5) 40 to 49 y
ears (n = 16). Two patients >50 years old were excluded from the analysis b
ecause of age.
RESULTS: Ninety-two percent of patients <10 years old had premature pubarch
e at presentation, whereas clitoromegaly and acne were each present in only
20% of these younger subjects. With only patients <greater than or equal t
o>10 years old considered, presenting clinical features included hirsutism
(59%), oligomenorrhea (54%), acne (33%); infertility (13%), clitoromegaly (
10%), alopecia (8%), primary amenorrhea (4%), and premature pubarche (4%).
Among the patients greater than or equal to 10 years old, the prevalence bu
t not the degree of hirsutism increased significantly with age. Basal level
s of 17-hydroxyprogesterone in adolescents were significantly higher than t
he levels found either in children (<10 years old) or women 40 to 49 years
old (P <.01 and P <.03, respectively), although no difference was noted in
the stimulated 17-hydroxyprogesterone levels between age groups: The adreno
corticotropic hormone-stimulated levels but not the basal levels of 17-hydr
oxyprogesterone were significantly higher in patients with clitoromegaly th
an in women without clitoromegaly. Alternatively, there were no differences
in either basal or stimulated 17-hydroxyprogesterone levels between patien
ts with and those without hirsutism, acne, or alopecia.
CONCLUSION: In children <greater than or equal to>10 years old the most com
mon presenting complaint was premature pubarche, whereas hirsutism and olig
omenorrhea were more common in older patients. The prevalence of hirsutism
increased with age, suggesting the progressive nature of nonclassic adrenal
hyperplasia. Furthermore, the adrenocorticotropic hormone-stimulated level
s of 17-hydroxyprogesterone were higher in patients with clitoromegaly, whi
ch suggests that the degree of adrenocortical dysfunction in nonclassic adr
enal hyperplasia determines, at least in part, the clinical presentation.